How to buy Ergomed (ERGO) shares

Learn how to easily invest in Ergomed shares.

Ergomed Plc (ERGO) is a publicly traded biotechnology business based in the UK. In the week up to 20 September Ergomed shares plunged 11.70% to a closing position of 1132p. Over the last 12 months, Ergomed's share price has fallen by 9.02% from 1275p. Ergomed is listed on the London Stock Exchange (LSE) and employs 1,371 staff. All prices are listed in pence sterling.

How to buy shares in Ergomed

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: ERGO in this case.
  5. Research Ergomed shares. The platform should provide the latest information available.
  6. Buy your Ergomed shares. It's that simple.
The whole process can take as little as 15 minutes. You'll need a smartphone or computer, an internet connection, your passport or driving licence and a means of payment.

Fees for buying 50x Ergomed shares with popular platforms

Share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform Platform fee Min. initial deposit Trading fee estimate
eToro Free Stocks logo £0 $10 £0.00
£580.00 total
Capital at risk
IG Share Dealing logo £0 £250 £8.00
£588.00 total
Capital at risk
Fineco logo £0 No minimum £0.00
£580.00 total
Capital at risk
Hargreaves Lansdown Fund and Share Account logo £0 £1 £11.95
£591.95 total
Capital at risk
Degiro Share Dealing logo £0 £0.01 £1.83
£581.83 total
Capital at risk
interactive investor Trading Account logo £9.99 per month No minimum £7.99
£587.99 total
Capital at risk
Halifax Share Dealing Account logo £36 per year £20 £9.50
£589.50 total
Capital at risk

Full comparison of share dealing platforms

Ergomed share price (LSE:ERGO)

Use our graph to track the performance of ERGO stocks over time.

Ergomed price performance over time

Historical closes compared with the last close of 1160p

1 week (2022-09-22) -1.19%
1 month (2022-08-26) 0.17%
3 months (2022-06-29) 16.00%
6 months (2022-03-29) -13.11%
1 year (2021-09-29) -9.02%
2 years (2020-09-29) 52.63%
3 years (2019-09-27) 293.22%
5 years (2017-09-29) 530.43%

Is it a good time to buy Ergomed stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page.

Promoted
IG bxs hero

Invest in Ergomed shares with IG

  • No commission on US shares
  • More than 13,000 shares to invest in
  • Open your account in minutes

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is Ergomed under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value.

P/E ratio

Ergomed's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 45x. In other words, Ergomed shares trade at around 45x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

EBITDA

Ergomed's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £21.6 million.

The EBITDA is a measure of a Ergomed's overall financial performance and is widely used to measure a its profitability.

Ergomed shares at a glance

Information last updated 2021-07-09.
Open1165p
High1200p
Low1150p
Close1160p
Previous close1200p
Change-40p
Change %-3.3333%
Volume17,118
Information last updated 2022-09-26.
52-week range910p - 1585p
50-day moving average1166.22p
200-day moving average1171.11p
Wall St. target price1425p
PE ratio45.44
Dividend yield0p (0%)
Earnings per share (TTM)0.25p

Ergomed share dividends

We're not expecting Ergomed to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.

Share price volatility

Over the last 12 months, Ergomed's shares have ranged in value from as little as 910p up to 1585p. A popular way to gauge a stock's volatility is its "beta".

ERGO.LSE volatility(beta: 1.05)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Ergomed's is 1.0519. This would suggest that Ergomed's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Frequently asked questions

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site